Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

36

Number of overlapping holdings

42.4%

% of WDNA's 90 holdings also in XBI

27.1%

% of XBI's 134 holdings also in WDNA

Overlap by Weight
Sector Drift (WDNA minus XBI)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in WDNA
Weight
in XBI
Overlap
NATERA INC 4.0% 2.5% 2.5%
UNITED THERAPEUTICS CORP 1.8% 2.3% 1.8%
BLUEPRINT MEDICINES CORP. 2.5% 1.7% 1.7%
SAREPTA THERAPEUTICS INC 1.6% 2.1% 1.6%
ALNYLAM PHARMACEUTICALS INC 1.5% 2.5% 1.5%

Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to XBI
NOVOZYMES A/S-B SHARES 3.5%
TWIST BIOSCIENCE CORP. 3.0%
VERICEL CORPORATION 2.4%
ELI LILLY & CO 2.3%
VERACYTE INC 1.7%
NATERA INC 1.5%
GERON CORP 1.5%
NEOGENOMICS INC 1.5%
AGIOS PHARMACEUTICALS INC 1.5%
DANAHER CORP 1.4%
WDNA Underweight Relative to XBI
NEUROCRINE BIOSCIENCES INC -2.8%
ABBVIE INC -2.5%
INSMED INC -2.4%
INCYTE CORP -2.4%
VAXCYTE, INC. -2.3%
HALOZYME THERAPEUTICS INC -2.1%
MADRIGAL PHARMACEUTICALS, INC. -1.9%
TG THERAPEUTICS INC -1.8%
MODERNA, INC. -1.8%
VIKING THERAPEUTICS, INC. -1.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY